Where To Invest Newsletter June 5, 2017

where to invest now newsletter

 Where To Invest Newsletter June 5, 2017

June 5, 2017

Where To Invest in June 2017

Market Strategies Newsletter Sample Issue


Where To Invest Newsletter


Balanced Investing Strategies To Make Money In Up Or Down Markets


A Publication of Princeton Research, Inc. (www.PrincetonResearch.com)

Contributing Staff: Michael King, Charles Moskowitz


Proven Trading Success

Some Of Our WINNING TRADES In 2017:

226% Profits on SPY Calls in 2 Days
125% Profits on SPY Calls in 2 Days
100% Profits on SPY Puts in 1 Day
175% Profits on SPY Puts in 3 Days
57% Profits on JBLU Calls in 8 Days
100% Profits on SPY Puts in 1 Day
163% Profits on SPY Calls in 2 Days
20% Profits on AGQ Calls in 15 Days
89% Profits on SPY Calls in 1 Day
130% Profits on GS Calls in 9 Days
217% Profits on XOM Calls in 9 Days
105% Profits on XOM Calls in 3 Days
117% Profits on GLD Calls in 3 days
62% Profits on XOM Calls in 20 days
50% Profits on PFE Calls in 2 Days
31% Profits TWTR Calls in 2 Days
316% Profits on MOS Calls in 13 Days
87% Profits on AMZN Calls in 2 Days
96% Profits on K Calls in 17 Days
16% Profits on HOG Calls in 8 Days
163% Profits on SJM Calls in 23 Days
102% Profits on AMBA Calls in 7 days
250% Profits on WTW Calls in 1 Day
128% Profits on WTW Calls in 1 Day
148% Profits on NVDA Puts in 2 Days

These are all of our most recent trades. This presents are Trade Alerts abilities to limit losses, KEEP GAINS and MAXIMIZE PROFITS to deliver strong returns to our trade alert members.


Join Today to Start Getting Profits Like These.

When you become a Trade Alerts Member:

We Do The Research and Analysis Work,
We Send You The Buy Trades,
You Make The Trades,
We Let You Know When We Are Selling,
You Take and Keep Your Gains.

To get trade alerts WHEN WE MAKE THEM, become a Member today. Go To:


To get the lowest full membership rates available now.


Where To Invest newsletter

Join Us Today.

Lock in the Lowest Membership Rates Available HERE

Gain access to BOTH Services:

Investing Trade Alerts
and The In-depth Market Strategies Where To Invest Newsletter


A Sample of the Where To Invest Now Newsletter Information Our Members Get Follows


Where To Invest in June 2017

Investing Trade Alerts

Charles Moskowitz Discussion


Open Positions:


Long 4 SIG June 55 Calls

Long 5 SPY June 9th 243.50 Calls

Long 6 SMG June 90 Calls

Long 2 SJM June 130 Calls


Funds in Use $ 1171.


Week 22 was another gain of $862 bringing YTD gains up to another new high of $6,884 or just under 69%.  The main component of the gain was our old favorite SIG, which we had played on the short side for the better part of a year ($130 to the mid80s) and switched over to the long side for a 2-day gain of about 200%.  We also rolled up in price from the June 50 calls and are now long June 55s.  We are also long some SPY, SMG, and the second half of our SJM.  Funds in use are only $1,171.


The markets made new highs again this week with the exception of the Transports and Russell 2000, but as mentioned in my Daily Notes, while the Transports are generally thought to lead the market, they have consistently been in catch-up mode recently.  They are just 300 points (3%) from giving us another “Dow Theory” breakout, and the Russell is a scant $20 (1.4%) to its peak.  Add to that the A.A.I.I. Sentiment numbers on page 3, which show further deterioration in Bulls and you have a situation where 70% of investors are either bearish or neutral, and that is not typical of a reversal top coming anytime soon.  The only issue (as in 3/12 selloff) is that political and geopolitical issues with this administration appear out of nowhere.  Fortunately the “but the dips” mentality still prevails, and they will continue, right up until they don’t.  This is one of the reasons

I don’t roll up position size.  It’s like doubling of nothing, eventually you get caught.


The problem that I am seeing is that the two weakest sectors are financials and energy.  The reason this is troubling is that it is difficult to continue to have a strong bull market without financials.  The interest rate picture is not nearly as clear as “the Fed is raising rates and that’s good for the banks.”  The bond market is a bigger and frankly more honest market and the yield curve has flattened of late.  This is decidedly not good for the banks or the economy.  Flattening yield curves precede recessions, and although it is usually too late for the Fed to realize (their numbers are backward-looking) there’s not much to do when rates are still close to zero.  Energy seems to be stuck in the trading range with the oil between $45-53, while natural gas seems to be driven lower by the cooler weather and has been driven straight down from $3.25 to under $3 in just the last 4 trading days.  If it doesn’t hold $2.80, $2.55 could be the next test.  With all the early summer driving increase, gasoline is still holding up slightly better, but a break of Friday’s low of $1.5545 would send it to test $1.48-1.50.


I will continue to look for opportunities in individual stocks but as mentioned every week for the last month, as long as the volatility stays low and premiums on the short-dated SPY options remains low, we will continue to make trades in that market. CAM



Where To Invest in June 2017

Investing Trade Alerts Summary

$10,000 Trading Account Trade Table


Sold 5 SPY June9th 243.50 Calls
    310 Gain
Sold 2 SJM June $130 Calls 100% Profit Rule
    360 Gain
Bought 10 SPY June 9th 243.50 Calls
Sold 2 SIG June $50 Calls later same day
    390 Gain
Sold 2 SIG June $50 Calls( 100% Profit Rule )
    150 Gain
Bought 4 SIG June $50 Calls
Sold 6 JPM June $86 Calls ( 50% Loss Rule )
    228 Loss
Sold 10 SPY May 31st $ 241.50 Calls
      40 Loss
Bought 10 SPY May 31st $ 241.50 Calls
Bought 6 JPM June $86 Calls
Sold 10 HL June $6 Calls
      80 Loss
Bought 2 SJM June $ 170 Calls
Bought 2 SJM June $ 130 Calls
Bought 10 HL June  $ 6 Calls


3rd Week expiration when the month is listed without a date


Previous closed out trades not listed here may be seen in previous market letters in the

VIP Subscribers Members Area.


Remember, these trades are based on your participation in the

Subscriber Members Only




New Trades Will Be TEXTED To MEMBERS


Options Trading Service That Makes Money

Where To Invest in June 2017

Fundamental Analysis Stocks To Buy with Stops


Using fundamentals the following are stocks to trade hypothetically. They have done well. We have taken numerous profits as indicated on the table below. In addition many have been stopped out with small losses.  All indicated on the table below.


Balance is critical.


Alibaba has made a few points. We are raising the stop loss price. Semiconductors are a leader on Nasdaq.


We remain long SIMO.


We have no position in Alcoa AA. If long use the 50 day price m.a. as a risk point.


Flushing Financial FFIC fell to and held the 50 day price moving average on March 3rd, which was a buying opportunity. We would buy the Flushing Financial.


Boeing is on its way to $ 200.


We are not involved with Bristol Myers.


Hecla Mining is a buy as long as it is above the 13 day price moving average.


We took profits on ENZ but still want to buy at lower prices.


The HDGE is finally relevant at this time. It is a decent long as long as it holds above its 50 day price moving average.


Symbol Name Business Description PE P/S MV mln Price Buy or Sell Limit Stop Loss

Or offset

BABA Alibaba China; more of a retailer than Amazon 50.67 13.21 275.5B 124.13 Bought @ $ 111 on 4/7/17 opening 121x
AMZN Amazon Catalog & Mail Order 189 2.90 394B 1006.73 Long Sell on stop 976x
SIMO Silicon Motion Semiconductor solutions for mobile storage and communications 9.7 2.5 1.39B  53.77 Bought



CIO City Office


Real Estate Investment Trust high quality Offices 292 5.8 396Mln  12.72 Re Bought at 12.12 11.50x
TPC Tutor Perini Construction 12 0.25 1.3B  26.55

Stopped out28.90




Looking for place to buy
SAVE Spirit Airlines Discount Airline 13 1.6 3.6B  55.83  48.10 Buy on a dip to $ 52 or close above $54.40
BMY Bristol Myers Biopharmaceutical Products 28 5.1 94.9B  54.97

No position


Sold  at 52.80x


Has no direction
BA Boeing Aerospace, commercial jetliners, military systems 14 0.85 81B 190.23  Long at

   132 10/04/16     

New stop loss at $ 179
HL Hecla Mining Basic Materials 44 3.61 1.7B    5.73

Look for re-entry

  Long at     5.30



A good long
FFIC Flushing Financial Bank Holding company Savings and loans 13 3,5 592Mln   28.32  19.10


50 day m.a. at 27.45
AA Alcoa Aluminum Processing and Technology N/A 0.4 9.5B  32.86


21.15 originally bought 2/8/16 $ 32.10 – 32.75 support
ENZ Enzo Biochem Life Sciences NA 1.35 134M   9.37 Bought

 at   5.13


Sold on Opening Monday 4/3/17

Sold 8.43

BAC Bank of America Commercial Bank 10 2.02 165.3B  22.45


Bought  at 15.42


23.60x stopped out on 3/21/17
HDGE Advisor Shares Ranger Bear ETF         8.72


 Stopped out on   5/24 Must close above 8.85 to be long



Where To Invest in June 2017

MARKET Laboratory – Weekly Changes


Prices are copied from Barron’s Weekly and Yahoo Finance and may be incorrect.



21,206.29            +126.01






S&P 500








Russell 2000








Gold (spot)




  Silver July




Crude June




Heating Oil




Unleaded Gas




Natural Gas








Put/Call Ratios

S&P 100           110/100’s


Put/Call Ratios

CBOE Equity





154-27  +2-07

2.81% -0-06%

10 Yr. Note

126-20 +0-27  2.16%-0-06%






CRB Inflation





Barron’s* Confidence







5 Yr.Note

118-15 +0-12







DJ Utilities
























M1 Money




May 22nd


M2 Money




May 22nd




* Component Change in the Confidence Index


M1…all money in hands of the public, Time Deposits Traveler’s Checks, Demand Deposits
M2.. adds Savings and Money Market Accounts both compared with the previous year.



Where To Invest in June 2017

Market Strategies Technical Information


                                                                   SUPPORT             RESISTANCE

S&P 500                   2406                                          2470

NASDAQ (QQQ)   140.60                                        143.50

Trans                            8950                                         9320

DOW                      20,800                                         21,360

TLT                        122.70                                          126.80

The suggested resistance at 143.50 held last week; higher levels become euphoric.




Get the lowest full membership rates available.



Follow Our Marketed Weathered,

Time Tested Trading Rules That



Now you can profit from investing trade alerts from our traders with over 75 combined years of successful investing experience.


  • Make Money In Up Or Down Markets — Our trading alerts balanced investing strategies are designed and proven to make money in up or down markets.


  • Done For You – All the stock options picking, research and trading analysis is done for subscribers. This is not a ‘class’ or a ‘training course’… this is us doing ALL the work… from research to sending you a text on what to trade, along with recommended amounts…


  • SAFETY – We strictly follow our Tested, Market Weathered Trading Rules that are proven time and time again to protect our (and now your) investment capital from losses while effectively allowing us to Keep The Profits We Make.


So even though we trade options to get the profits you see above — We can do it with minimal risk and Maximum Profit Potential.


You Don’t Need To Learn Any Trading Skills Or

Do Any Time Consuming Analysis and Tracking


+++ We DO IT ALL FOR YOU! +++


Where To Invest in June 2017

Previous Week’s Recommendations and

Rules for the Market Strategies

$100,000 Portfolio Trading Account


  • All options count for about $ 2,500.00 for model portfolio calculations unless

otherwise stated


  • When the option has doubled sell half the position


  • Stop Loss protection is either half or offered with each trade


  • The cost of the option is the asking price (or the price between the bid and ask,

whichever is more realistic)


  • The options will be followed until closed out.


  • Option Symbols are stock symbol with expiration month and strike price


Option Cost Date Sold Date Profit



10 lots remain



06/01/17 1.24

(Sold half 100% profit Rule)

06/02/2017 $ 620
SIG June 50

8 lots



05/31/17 1.50

(100% profit Rule sold half)



Sold Balance Later Same Day





$ 300



$ 780

JPM June 86

12 lots



05/30 17 0.38

( 50% Loss Rule )

05/31/2017 ( $ 456 )
SPYMay31 241.50

20 lots



05/30/17 0.36 05/30/2017 ( $ 80 )
SIG June 60

1 lot



05/17/17 4.70 06/01/2017 $ 255
SIG June 60

1 lot



06/01/17 3.90 05/17/2017 $ 270
SJM June 130

4 lots left at $ 1.60




05/01/17 3.50

( 100% Profit Rule )

06/02/2017 $ 720
HL June 6

20 lots



04/21/17 0.16 05/30/2017 ( $ 160 )


Recommendations will be both listed in this letter and texted to members.


Previous closed out stock and option positions can be found in past Market Strategies Newsletter issues available in the VIP Subscribers Members Area.


Where To Invest in June 2017

This Weeks’ Economic Numbers

Earnings Releases and Media Data


Before the Open on top of the Row;

After the close below the Economics Information


MONDAY JinkoSolar Holding JKS ( 0.41 vs 1.72 )


Markets are closed in Austria,France and Germany for a religious holiday

08:30 hrs Productivity-Rev 1st Qtr ( -0.2% vs -0.6% )

08:30 hrs Unit Labor Costs- Rev ( + 2.4% vs + 3.0% )

10:00 hrs Factory Orders April ( -0.2% vs +0.2% )

10:00 hrs ISM Services May ( 57.0 vs 57.5 )


Casey’s General CASY ( 0.84 vs 1.19 )Coupa Software COUP -0.14 Thor THO  1.86 v 1.51

TUESDAY Canadian Solar CSIQ ( -0.27 vs 0.39 ) Conn’s CONN ( -0.22 vs -0.31 ) HD Supply Holdings HDS ( 0.66 vs 0.51 ) Michaels Stores MIK 0.39 vs 0.36 Secure Wks SCWX (-0.06 vs -0.09 )

The Organization for Economic Cooperation and Development holds a forum in Paris

10:00 hrs Jolts-Job Openings April ( NA vs 5.743 Mln Units  )


Markets are closed in South Korea for Memorial Day


Ambarella AMBA ( 0.36 vs 0.34 Analogic ALOG ( 0.74 vs 0.80 ) Ascena Retail Group ASNA

( 0.05 vs 0.15 ) Dave&Busters PLAY ( 0.82 vs 0.72 ) Keysight KEYS ( 0.58 vs 0.61 ) United Natural Foods UNFI ( 0.76 vs 0.76 ) NCS Building Systems NCS ( 0.11 vs 0.04 )


WEDNESDAY At Home Group HOME 0.19 Brown-Forman BF.B 0.40 vs 0.84 Navistar NAV -0.02 vs 0.05



07:00 hrs MBA Mortgage Applications Index 06/03 ( NA vs -3.4% )

10:30 hrs Crude Inventories 06/03l ( NA vs -6.43Mln Bbls  )

15:00 hrs Consumer Credit April (  $15.0B vs $ 16.4B )


ABM Idustries ABM ( 0.42 vs 0.31 ) Greif GEF ( 0.74 vs 0.47 ) Tailored brands VRNT 0.38

THURSDAY J.M. Smucker SJM ( 1.72 vs 1.19 ) Vail Resorts MTN 4.88 vs 4.23 

08:30 hrs Initial Claims 06/03 ( 240K vs 248K )

08:30 hrs Continuing Claims 05/27 ( NA vs 1915K )

08:30 hrs Productivity- Rev 1st Qtr  ( -0.6% vs -0.6% )

10:30 hrs Natural Gas Inventories 06/03 ( NA vs 81bcf )

New-issue price regulations go into effect in the Muni-Market.

The United Kingdom holds a general election; The margin between Prime Minister Theresa May and Jeremy Corbyn has been narrowing.

Former FBI Director James Comey testifies before the Senate Intelligence Committee.

Argan AGX 0.89 Layne Christensen LAYN ( -0.30 vs -0.45 ) VeriFone PAY ( 0.29 vs 0.47 )

 FRIDAY Ferrelgas Partners FGP ( 0.12 vs 0.19 ) KMG Chemicals KMG 0.47


China releases monthly numbers on PPI and CPI

10:00 hrs Wholesale Inventories April ( -0.1% vs +0.2% )



The U.S. Oil Rig Count increased by 2 Rigs to 722. One year ago there were 404 rigs in use. The Nat Gas Rig count increased by 5 to a total of 185 making a total rig count of 907. It was the nineteenth weekly rig count rise in a row. Crude closed lower at $47.66, down 4.3% or  $2.14.   Natural Gas closed the week off $  0.311 or -9.4%,  at $ 2.999



Where To Invest in June 2017

Market Strategies Cycles


Last week the S&P 500 completely recovered making new all – time highs and more than making up the losses from Wednesday, May 17, when the market suffered the worst day of the year. Prior to that day, VIX (CBOE Volatility Index) was at historic lows trading at less than 10 for four straight days and actually closed below 10 on May 8 & 9. VIX then slowly inched higher and closed at 10.65 on May 16. Today, VIX closed at 10.68. VIX and the broader market are essentially right back where they were one week ago, but it took four trading days to recover that single day’s loss.


VIX’s 46.4% jump on May 17 could have been the first sign that the seasonal low in volatility has already been reached this year. However, it was an anomaly. The solid bull market likely continues into June.


In the following chart, from the Stock Trader’s Analyst, the VIX weekly bars appear on top with its 1-year seasonal pattern appearing on the bottom. In a typical year, VIX typically finds a bottom sometime from mid-April to mid-July before briskly rebounding higher through frequently turbulent August and September; since 1950, September has been the worst month for S&P 500 and August is second worst based upon average percent change to a peak in early October. From then until the following April, during the “Best Six Months,” VIX is generally in decline as the market is climbing higher. The VIX continues to succumb to the lows for 2017, as the stock market makes new highs.




ProShares UltraShort Silver (ZSL) and the short position in SPDR Gold (GLD) were sold by the Stock Trader’s Almanac using the average prices on May 19.


ZSL and short GLD were exited for an average loss of 3.9%. A weakening U.S. dollar and a significant improvement in Stochastic, relative strength and MACD indicators applied to gold and silver prices were factors in reversing these positions. Long half-positions in iShares Silver (SLV) and GLD were established on May 18 when both traded below their buy limits. SLV and GLD longs are currently up an average 1.3%. GLD and SLV can still be considered on weakness..








This week’s award goes to David Templeton of HORAN Capital Advisors for his timely refutation of the latest “scary chart.” It is so easy to create these bogus parallels. If you want page views or retweets, this is the ticket. Here is the chart making the rounds:

And here is what you get if you use percentage changes since the absolute price levels are not similar:


The Week Ahead

We would all like to know the direction of the market in advance. Good luck with that! Second best is planning what to look for and how to react. That is the purpose of considering possible themes for the week ahead. You may be able to make your own predictions in the comments.




Undervalued Small Cap Stocks


Lower priced stocks that look to be a buy:


Lower Capitalized Companies with Great Potential


RMS Medical Products ( REPR: $ 0.45 )


“RMS” or the “Company” is pleased to announce that the umbrella organization of the public health insurance in Germany approved the FREEDOM60® Infusion System for reimbursement. The FREEDOM60® System was registered January, 31st 2017 and listed in the Medical Device Registry in the category mechanical infusion pumps.  It is the ONLY device of its kind registered within Germany.


In partnership with ContraCare GmbH, a leader in Germany for Contract Management (reimbursement services) and managed Care, the RMS FREEDOM60®, FreedomEdge®, RMS Precision Flow Rate Tubing™ and RMS HIgH-Flo Subcutaneous Safety Needle Sets™ are now poised to dominate this growing market in Europe.


The United States Food and Drug Administration (“FDA”) renewed the Company’s Certificate to Foreign Government (“CFG”). A CFG is issued for legally marketed devices in the U.S. that are in compliance with the requirements of the Federal Food, Drug, and Cosmetic Act (“FFDCA”). A CFG is required by many market regulators in Asia, Europe, the Middle East and Latin America in order to legally sell medical devices in their territories. The renewal of this CFG confirms RMS devices have been cleared for sale in the U.S. and are in compliance with the requirements of the FFDCA. The CFG can be presented to regulators in foreign markets as part of the medical device registration process. Foreign governments often seek official assurance that products exported to their countries can be marketed in the U.S. and meet specific U.S. regulations, for example, current Good Manufacturing Practice (“cGMP”) regulations and Quality System Regulations (“QSR”).


Torsten Kühn, Chief Executive Officer of ContraCare, commented “as a premium service provider in Germany’s health care system, we aim to partner with leading suppliers to provide the best drugs, medical devices and services to our patients while keeping an eye on the cost efficiency of the treatments we provide. The RMS FREEDOM60® system with its durable and reliable syringe driver and high-quality HIgH-Flo™ subcutaneous safety needle sets are exactly the products we needed for immunoglobulin, antibiotic and many other therapies we are providing today. We are glad that the umbrella organization of Germany’s public health insurance confirms the unmet need by approving the RMS FREEDOM60® System for reimbursement.”


Eric Bauer, Chief Operating Officer of RMS commented, “It can take 12 to 14 months to obtain country registration; by partnering with a leading health care provider, that time was cut significantly.  Contra Care is an exceptional partner and we could not be more pleased with our relationship. Germany is going to be a great market for our high quality products and our ever expanding product line.  RMS continues to be the Global industry leader and create exceptional partnerships around the world to improve patient quality of life.”

RMS Medical Products is the leading manufacturer of medical products used for home infusions and suctioning. The Infusion product portfolio currently includes the FREEDOM60® and our latest Freedom Edge® Syringe Infusion Drivers, RMS Precision Flow Rate Tubing™ and RMS HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in professional healthcare settings as well as at home. The Company’s RES-Q-VAC® line of medical suctioning products is used by emergency medical service providers in addition to a variety of other healthcare providers. The Company’s website may be visited at www.rmsmedicalproducts.com.

Contra Care GmbH, based in Nuremberg, Germany, is specialized in providing Contract Management (reimbursement) Services and managed Care (homecare) solutions for patients with chronic diseases. The company is certificated in accordance with ISO 9001, ISO 27001, ISO 13485 and licensed as a homecare provider of medical devices and treatment services according to German Social Law (SGB).


Enzo Biochem ( ENZ: $ 9.37 )


Enzo Biochem closed the calendar year 2016 at $6.94 a share. For the year it was up 54.22% versus the Dow Jones +13%. The relative strength index was 53.41 which is neutral and short interest declined to 827,800 shares. However the RSI has climbed to over 80 and is now 69.08 on April 1st, 2017. Enzo’s balance sheet closed their first quarter October 31 with $67 million in cash and current equivalents and complete elimination of debt. Both the Clinical Lab and Life Science divisions ended the year profitably. New products were added to their catalog and litigations have moved ahead leaving them as a plaintiff with 6 lawsuits in the Delaware Court and one in the Manhattan Court.


What do I look for in 2017? The market will be interesting in the first half with the Government transition to a new administration. Abbots Summary Judgement request was denied by the Court but the trial date has yet to be set. At some point the 2nd Court of Appeals will rule on Enzo’s appeal on the CT. Courts reversal of the Jury’s decision in the Enzo vs. Apalera Case. The market is giving no value, win or lose, to this decision. The stake is $65 million with no adverse effect if ruled against Enzo. Enzo should again outperform the Dow and S&P in 2017.

Updates on Delaware Litigation

The last earnings report showed a cash position in excess of $65 million with no debt to speak of and a positive cash flow from their operating divisions. The only cash burn is coming from Litigation expenses and a bit from Research and Development. Litigation in Delaware is on a contingency basis as such Enzo is not on the hook for billable hours. To my knowledge there are 6 suits left after 6 have settled.

When the company gets a 500 million dollar market cap ($10.63) they will qualify for those Institutions that can’t buy microcap stocks. A significant number of Institutions will look to be buyers and with only 47 million shares issued and Institutions already owning 50% and insiders owning 15% that leaves less than 17 million shares in the float.


Pressure Bio Sciences OTCQB: PBIO ( 0.22  )*


Recently announced the signing of a new CFO Mr. Joseph L. Damasio Jr. Mr. Damasio has over 20 years of finance and accounting experience most recently as Finance Director at Nelipak Packaging, a private equity backed medical packaging manufacturer with over $ 100 million in global annual sales. Before joining Nelipak, Mr. Damasio held financial positions at CP Bourg, IQEKC, and Kopin Corporation. Mr Damasio was employed by Pressure BioSciences as both accounting manager (2007) and controller (2008) and finally as Vice President of Finance and Administration (2011).

The hiring of Mr Damasio will allow the Company’s CEO Mr Richard T Schumacher, who has been the company’s interim CFO for the past two years, and who has been a successful serial life sciences entrepreneur with three successful publicly traded companies to his credit, time to focus on critical operational issues in 2017. Some issues to be attended to include a pending up-list to NASADAQ and their stated goal to build a field sales team this year.

PBIO Develops, markets, and sells proprietary laboratory instrumentation and associated consumables to the estimated $6 billion life sciences sample preparation market. Products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions. To date, they have installed over 250 PCT systems in approximately 160 sites worldwide. There are over 100 publications citing the advantages of the PCT platform over competitive methods, many from key opinion leaders.

NEEDS IN MEDICINE: In the world of medicine our dramatically improved ability for early detection or to confirm and refine diagnosis ranging from over a hundred types of cancer to tuberculosis and a hundred other maladies and conditions is “bottlenecked” by 30 year old methods of preparing test samples.  Collectively such diagnostic samples exceed a hundred million annually.

NEEDS IN RESEARCH: Globally there are over a half a million medical and pharmaceutical research scientists working in over eighty thousand laboratories who are hampered by the time consuming and outdated methods of preparing test samples.

NEEDS IN FORENSICS: Globally, in millions of cases, swift and sure exoneration of the innocent and / or justice for the guilty is often delayed or even denied because of the ponderous means of preparing and conducting DNA and other forensic testing.

PBIO is focused on solving the challenges of biological sample preparation, a crucial laboratory step performed globally by the biological life sciences research scientists. Sample preparation refers to a wide range of activities that precede most forms of scientific analysis. It is often complex, time-consuming and, in our opinion, one of the most error-prone steps of scientific research. Sample preparation is a ubiquitous laboratory undertaking – the requirements of which drive a large and growing worldwide market. PBIO has developed and patented a novel, enabling technology platform that can control the sample preparation process while improving both efficacy and quality.  It is based on harnessing the unique properties of high hydrostatic pressure. This process, called pressure cycling technology, or PCT, uses alternating cycles of hydrostatic pressure between ambient (normal atmosphere) and ultra-high levels i.e., 35,000 pounds per square inch (“psi”) or greater to safely, conveniently and reproducibly control the actions of molecules in biological samples, such as cells and tissues from human, animal, plant and microbial sources.


The PBIO pressure cycling technology uses proprietary and internally developed instrumentation that is capable of cycling pressure between ambient and ultra-high levels at controlled temperatures and specific time intervals, to rapidly and repeatedly control the interactions of bio-molecules, such as deoxyribonucleic acid (“DNA”), ribonucleic acid (“RNA”), proteins, lipids and small molecules. Their laboratory instrument, the Barocycler®, and their internally developed consumables product line, which include Pressure Used to Lyse Samples for Extraction (“PULSE”) tubes, and other processing tubes, and application specific kits such as consumable products and reagents, together make up their PCT Sample Preparation System (“PCT SPS”).


The PBIO pressure cycling technology takes a unique approach that has the potential for broad use in a number of established and emerging life sciences areas, which include:


  • Biological sample preparation in potentially thousands of research laboratories worldwide working in human, animal, plant, and microbial diseases and disorders – including but not limited to sample extraction, homogenization, and digestion in genomic, proteomic, lipidomic, metabolomic and small molecule study areas;


  • Pathogen inactivation (useful in vaccine development, infectious disease research, and more);


  • Protein purification, and in the control of chemical reactions, particularly enzymatic (useful in drug design and development);


  • and immunodiagnostics (useful in the development and detection of biomarkers).




PBIO has secured their technology through fourteen issued United States patents and ten issued foreign patents covering multiple applications of pressure cycling technology in the life sciences field.  They also have additional patents pending.  Research indicates that Pressure Bio Science, Inc. is the only company globally to have patents in this new science sector.



NightFood, Inc. (NGTF 0. 30 )* 


Has healthy night-time food specially formulated for nighttime snackers. The Company has an exclusive agreement with RFI, natural ingredient manufacturer and proprietor of Chocamine, a patented cocoa extract which helps with cravings and mood (calmness), and promotes feelings of satiety.


Americans keep gaining more weight. People have the tendency to grab for goodies at the end of the evening as they relax to enjoy some T.V. Eating and snacking too late at night is a contributing factor to gaining weight. Seventy percent of adults, ages 18-54, snack in the hour or two before bed. Chocamine delivers the health benefits of chocolate to the body (amino acids, minerals and polyphenols) without the added sugars, caffeine or fat.


People give in to the intense hunger cravings that leads to the consumption of sugary, salty or calorie dense foods to satisfy their appetite and cravings. Most of the snacks that people typically eat can impair sleep, causing a person to wake up feeling unrested. Night Food offers better-for-you alternatives to high-calorie and sleep disruptive junk foods.


The company product line currently includes snack bars in two flavors, either Cookies and Dreams or Midnight Chocolate Crunch.  The company recently reported that it is looking into expanding the number of flavors in the Night Food bar line, and also manufacturing products in different snack formats, like ice cream or “bites”


Consumers spend over $50 billion/year on night-time snacks…over $1B every week.  In general, snacking trends have shifted much healthier over the past several years, but industry research continues to show that the least healthy choices of the day occur as we get closer to bedtime.  In fact, the four most popular nighttime snack categories, in order, are salty snacks (chips, pretzels, popcorn), ice cream, chocolate candy, and cookies.


Management believes that, just as there are energy versions of many popular foods (energy jerky, energy candy, energy waffles, energy gum, energy chips, energy bars), foods can also be formulated to be more nighttime appropriate and sleep-friendly.

We’ve seen it happen with low-carb, we’ve seen it happen with gluten-free.  Can it happen with nighttime snacking as well?


Leo Motors (LEOM: $ 0. 11)*


has patents for the electric battery industry which we will be writing about in upcoming weekly reports. They have developed a lithium battery that can operate vehicles in sub-zero climates. Their subsidiary LGM has developed battery technology supported by the Korean government to make it possible to use electric battery technology for fishing boats. They have a cartridge system which is a light-weight replacement method of swapping electric batteries.


Fishing has been harmed by the noise and oil leaks from internal combustion engines. LGM has solved that problem and besides eliminating the toxic problem, operating costs are reduced by 25%.


In addition they have a special patent for averting electric hazards and shocks. Leo developed the Internet of Things for e-boats which is networked and connected with an Android Operating System. Leo’s power supply system is CAN (Controller Area Network) based, which enables mobile diagnostics between mobile devices and boats using the Leo technology.


Leo is developing a battery swap system for Kalmado in Puerto Princesa, Philippines, a world famous   tourist attraction, which is focused on green energy. They will be converting 100 boats as the environment is expected to become 100% free of the toxicity from internal combustion engines. Also, Leo has developed a battery swap system for Go-Karts to be used in malls in China, Korea and Myanmar. Leo Motors has a new carbon nanotube battery power pack that functions and supplies full power in extreme low temperatures such as below 49 degrees without the need for grid electricity.



Skinvisible  ( SKVI: $ 0.027  )*:


They have developed skin care products using its patented Invisicare polymer delivery systems and transdermal cannabis products from hemp-derived CBD, with its new developments to include cannabinoids from marijuana CBD and THC.


Transdermal Cannabis Products Stock on Investment News Show


Money Info Investing News Show features live interview with

Terry Howlett, President & Chief Executive Officer of Skinvisible, Inc. (Stock Symbol: SKVI)


See Show information here:




Hear Interview replay at link above or on Youtube at:






Rule 17B Attestations and Disclaimers


Princeton Research, Inc. has approximately 2,581,578 shares of AIVN both free and restricted and represents them for Investor relations. Princeton also has about 40,000 shares of TXGE. Princeton is paid $ 1,500 per month from RMS Medical Products. Princeton has bought 81,100 shares of RMS Medical Products. Princeton was paid $ 2,500 to write a report on Xinergy. Princeton has signed a contract with CBLI to be paid $ 2500 for July and August for investor relations. Princeton has been engaged by Target Energy. No contract is currently in place. Princeton was paid about 500,000 restricted shares of Leo Motors.


When there is no movement in penny stocks, even though there is none or very small losses, we will liquidate ( sold AIVN on stop ) even though we like the company, if money is needed for better opportunities.


We now believe REPR represents upside opportunity. The Target ADR trades at about $ 4.50 in U.S. vs 0.05 in Australia. Princeton owns 400,000 Australia shares and about 900 U.S. ADR’s.


Pursuant to the provisions of Rule 206 (4) of the Investment Advisers Act of 1940, readers should recognize that not all recommendations made in the future will be profitable or will equal the performance of any recommendations referred to in this e-mail issue. Princeton may buy or sell its free-trading shares in companies it represents at any time.




Please Direct All Inquiries To:


Mike King

(702) 650-3000